Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Matthew Summers

Interventional Cardiology Norfolk, VA Medical Doctor

NPI 1861781395 CMS profile 2788356

844 Kempsville Rd Ste 204, Ste 120, Norfolk, VA 23502

Open in the dashboard

General payments

$307,514

581 records reported · program years 2019–2025

Research payments

$263

Paid to them · 3 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$306,535 paid to institutions, not to them · program years 2022–2025

Through program year 2025, Matthew Summers of Norfolk, VA is reported in the CMS Open Payments database as having received $307,514 across 581 general payments and $263 in research payments paid to them. Separately, studies naming them as principal investigator received $306,535 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $153,531 167
2024 General $52,762 92
2023 General $21,201 79
2023 Research $263 3
2022 General $45,794 83
2021 General $26,897 59
2020 General $969 23
2019 General $6,361 78

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Summers
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Matthew Summers were reported at $153,531. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Matthew Summers Interventional Cardiology median Middle half National median
2019 $6,361 $1,097 $329–$3,048 $163
2020 $969 $473 $161–$1,480 $114
2021 $26,897 $677 $233–$1,827 $132
2022 $45,794 $978 $333–$2,724 $149
2023 $21,201 $1,136 $382–$2,986 $160
2024 $52,762 $1,181 $395–$3,326 $164
2025 $153,531 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $132,137 198 payments
  2. Abbott Laboratories $93,150 154 payments
  3. Shockwave Medical, Inc $30,146 21 payments
  4. Abiomed $28,754 43 payments
  5. Teleflex LLC $10,341 14 payments
  6. Edwards Lifesciences Corporation $3,892 34 payments
  7. Boston Scientific Corporation $2,550 44 payments
  8. Medtronic Vascular, Inc. $2,036 38 payments
  9. Philips Electronics North America Corporation $1,254 10 payments
  10. JenaValve Technology, Inc. $1,152 3 payments
  11. Other $2,102 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $99,664 36 payments
  2. Consulting Fee $95,972 29 payments
  3. Travel and Lodging $57,902 128 payments
  4. Honoraria $21,300 5 payments
  5. Food and Beverage $19,195 377 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $13,200 5 payments
  7. Long term medical supply or device loan $282 1 payment
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $129,595 160 payments
  2. NAVITOR Structural Heart $34,244 27 payments
  3. Impella $28,626 42 payments
  4. TRICLIP $27,944 32 payments
  5. Vascular Lithotripsy $22,639 16 payments
  6. NAVITOR Vascular $12,263 5 payments
  7. UroLift System $10,143 12 payments
  8. ENSITE PRECISION $7,721 3 payments
  9. Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter $7,507 5 payments
  10. AMPLATZER AMULET $3,403 4 payments
  11. Other $17,846 244 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abiomed $263 3 payments

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$371,405

Medicare's payments for the services billed

Medicare patients

608

Average age 78

Services billed

1,662

273 women, 335 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 70%
Ischemic heart disease 69%
Atrial fibrillation 50%
Arthritis 48%
Chronic kidney disease 41%
Diabetes 40%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

584 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record